As of Oct 27
| +0.02 / +0.91%|
The 2 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 5.65, with a high estimate of 8.00 and a low estimate of 3.30. The median estimate represents a +154.50% increase from the last price of 2.22.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.